Effect of antiplatelet persistence on longterm mortality and predictors of nonpersistence in ischemic stroke patients 75 years and older: A nationwide cohort study
We aimed to provide real-world evidence on the benefit of persistence with antiplatelet therapy (APT) on long-term all-cause mortality (ACM) in ischemic stroke patients aged 75 years and older.